Tim is a partner in Goodwin’s Technology and Life Sciences groups, based in the Cambridge and London offices.
Tim regularly advises life sciences companies on licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad spectrum of regulatory matters. His expertise also includes advising on the IP and regulatory aspects of M&A transactions, IPOs and venture capital investments. Outside of the life sciences sector, Tim advises technology companies on their technology licensing and commercial agreements.
Tim’s life sciences regulatory expertise includes advising on a broad range of medicinal product and medical device regulatory issues. He also carries out regulatory investigations for clients in the sector, and assists clients with regulatory due diligence in connection with transactions.
Prior to joining Goodwin, he was a partner and co-head of the International Life Sciences group at Taylor Wessing LLP. Tim was previously legal counsel and company secretary at Eli Lilly and Company Limited in the UK. He has a degree in Natural Sciences (Chemistry) from Cambridge University.
Over the last 15 years, Tim has advised numerous clients on licensing, transactional and regulatory matters in the life sciences sector.
Tim has lectured for a number of years for University College London’s course IP Transactions: Law and Practice.
Legal Practice Course1998
Nottingham Law School
Post Graduate Diploma in Law1997
Nottingham Law School
- England & Wales
Recognition & Awards
Tim is regularly featured in the leading UK legal directories. This year, Tim was recognized by Chambers and Partners UK (2023) for Life Sciences: Transactional, due to his extensive experience in licensing and partnering deals, as well as in advising on the IP and regulatory aspects of corporate transactions. He was also ranked in The Legal 500 UK (2023) as a Leading Individual in the Biotechnology category, and secured a place in their coveted ‘Hall of Fame’ for Intellectual Property to recognize continued praise from his clients in that area.
Moreover, Tim was recognized by Managing IP as a 2022 IP Star for his excellence across a variety of patent and transactional matters and by Who’s Who Legal as a Global Leader in both Life Sciences Regulatory and Transactional (2022).
Client testimonials cite:
- “Tim Worden is extremely knowledgeable and experienced on all aspects licensing transactions. A very calm but engaging personality. He is very good at highlighting and then resolving different challenges arising in a negotiation. I always have the impression nothing gets past Tim which gives me comfort we have the right lawyer representing us.”
- “Tim Worden provides super practical and pragmatic advice that is steeped in experience and he is valued in our business.”
- “Tim Worden is a fantastic contract lawyer and negotiator. His legal skill set is top and so is his negotiation skill set. Helped us tremendously through negotiations as our lead.”